Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Cholangiocarcinoma × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 233 Breast Neoplasms 127 Neoplasms 102 Prostatic Neoplasms 35 Fatigue 34 Obesity 24 Colorectal Neoplasms 22 Lung Neoplasms 20 Polycystic Ovary Syndrome 17 Colonic Neoplasms 15 Ovarian Neoplasms 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Lymphoma 11 Carcinoma, Non-Small-Cell Lung 11 Weight Loss 10 Pancreatic Neoplasms 10 Multiple Myeloma 10 Lymphedema 10 Hematologic Neoplasms 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Leukemia 9 Cardiotoxicity 9 Insulin Resistance 8 Stomach Neoplasms 6 Cognitive Dysfunction 6 Cachexia 6 Brain Neoplasms 6 Peripheral Nervous System Diseases 5 Overweight 5

Interventions

Gemcitabine 79 Cisplatin 49 Oxaliplatin 35 lenvatinib 24 Capecitabine 22 durvalumab 21 Fluorouracil 19 Leucovorin 14 tislelizumab 10 pembrolizumab 10 apatinib 10 Radiotherapy 10 Albumin-Bound Paclitaxel 10 Radiofrequency Ablation 9 Floxuridine 9 Magnetic Resonance Spectroscopy 8 Liver Transplantation 8 Irinotecan 8 Drug Therapy 8 Cholangiopancreatography, Endoscopic Retrograde 8 130-nm albumin-bound paclitaxel 8 Taxes 7 Photochemotherapy 7 Panitumumab 7 tremelimumab 6 pemigatinib 6 camrelizumab 6 Surgical Procedures, Operative 6 Radiosurgery 6 Platinum 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02162914 2020-07-31

REACHIN

Erasme University Hospital

Phase 2 Unknown

Gastrointestinal

Neoplasm Metastasis, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡